ALENDRONATE PLUS D3 CALCIUM ACTAVIS alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alendronate plus d3 calcium actavis alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg

dr reddys laboratories australia pty ltd - alendronate sodium,colecalciferol,calcium carbonate,microcrystalline cellulose -

ALENDRONATE PLUS D3 and CALCIUM SANDOZ alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alendronate plus d3 and calcium sandoz alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500

dr reddys laboratories australia pty ltd - alendronate sodium,calcium carbonate,colecalciferol,microcrystalline cellulose -

REDDYMAX PLUS D-CAL alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg tablet composit Australia - engelsk - Department of Health (Therapeutic Goods Administration)

reddymax plus d-cal alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg tablet composit

dr reddys laboratories australia pty ltd - alendronate sodium,calcium carbonate,colecalciferol,microcrystalline cellulose -

SIGNIFOR pasireotide 900 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 900 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 1128.6 microgram (equivalent: pasireotide, qty 900 microgram) - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; tartaric acid - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 300 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 300 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 376.2 microgram (equivalent: pasireotide, qty microgram) - injection, solution - excipient ingredients: water for injections; mannitol; tartaric acid; sodium hydroxide - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 600 microgram/1 mL (as diaspartate) solution for injection ampoule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 600 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 752.4 microgram (equivalent: pasireotide, qty 600 microgram) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; tartaric acid; mannitol - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

ALENDRONATE AN alendronic acid (as sodium alendronate) 70mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alendronate an alendronic acid (as sodium alendronate) 70mg tablet blister pack

amneal pharma australia pty ltd - alendronate sodium -

XYDEP sertraline (as hydrochloride) 100 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

xydep sertraline (as hydrochloride) 100 mg tablet blister pack

pfizer australia pty ltd - sertraline hydrochloride -

XYDEP sertraline (as hydrochloride) 50 mg tablet blister pack Australia - engelsk - Department of Health (Therapeutic Goods Administration)

xydep sertraline (as hydrochloride) 50 mg tablet blister pack

pfizer australia pty ltd - sertraline hydrochloride -

SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

spikevax bivalent original/omicron ba.4-5 (elasomeran/davesomeran) covid-19 vaccine 0.1 mg/ml suspension for injection vial

moderna australia pty ltd - elasomeran, quantity: 0.05 mg/ml; davesomeran, quantity: 0.05 mg/ml - injection, suspension - excipient ingredients: 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000; distearoylphosphatidylcholine; heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate; sucrose; trometamol; cholesterol; trometamol hydrochloride; sodium acetate trihydrate; water for injections; glacial acetic acid - spikevax bivalent original/omicron ba.4-5 (elasomeran/davesomeran) covid-19 vaccine is indicated for:,as a booster dose for active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2 in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19.,the use of this vaccine should be in accordance with official recommendations.